Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920330 · ClinicalTrials.gov registry record · NA
Nasal Obstruction and Olfactory Losses
A NA study of Nasal Obstruction, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 1
- Study location
NCT05920330: Recruiting NA study of Nasal Obstruction, sponsored by Ohio State University.
NCT05920330 is a NA study of Nasal Obstruction that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 330 participants, above the 84-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (293% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05920330, a NA study of Nasal Obstruction, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 1
- Study location
Study Summary
About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contributing to these symptoms. The proposed study aims to develop novel clinical tools to better evaluate and relieve patients' nasal obstructive symptoms and to enable patients and clinicians to make more informed, personalized decisions regarding treatment strategy.
Primary Outcome
A clinically validated 5 item questionnaire to document general nasal obstruction. symptoms severity.
Conditions Studied
Interventions
- OTHER Nasal Plug
Study Locations (1)
Ohio
- Eye and Ear Institute, 915 Olentangy River Road, ENT, Suite 4000 - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT05920330 shows while recruiting
NCT05920330 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, above the 84-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (293% higher).
The record links to 1 condition, with Nasal Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Nasal Plug is the first listed.
NCT05920330 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05920330 about?
NCT05920330 is a clinical study titled "Nasal Obstruction and Olfactory Losses". About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the disease that are crucial to disease management, currently there is a lack of clinical tools to effectively evaluate the mechanisms contribut...
What is the current status of trial NCT05920330?
This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2023-01-25. Estimated completion is 2028-12-31.
What conditions does trial NCT05920330 study?
This clinical trial studies the following conditions: Nasal Obstruction.
What interventions are being tested in trial NCT05920330?
The interventions under investigation include: Nasal Plug (OTHER).
Who is sponsoring clinical trial NCT05920330?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05920330 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
RECRUITING · NA
-
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
COMPLETED · NA
-
Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction
COMPLETED · NA
-
Nasal Obstruction With Oxymetazoline and Corticosteroids
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI